Multiple myeloma (MM) is a malignancy derived from plasma cells.
Advances in treatment have improved survival in MM patients; however, it remains incurable, and most patients will relapse.
Rescue treatments based on daratumumab, carfilzomib, and pomalidomide have shown good results internationally, but there is a lack of data on their effectiveness and safety in Chile.
